Basit öğe kaydını göster

dc.contributor.authorAygun, D
dc.contributor.authorDoganay, Z
dc.contributor.authorAltintop, L
dc.contributor.authorGuven, H
dc.contributor.authorOnar, M
dc.contributor.authorDeniz, T
dc.contributor.authorSunter, T
dc.date.accessioned2020-06-21T15:48:58Z
dc.date.available2020-06-21T15:48:58Z
dc.date.issued2002
dc.identifier.issn0731-3810
dc.identifier.urihttps://doi.org/10.1081/CLT-120016962
dc.identifier.urihttps://hdl.handle.net/20.500.12712/22099
dc.descriptionWOS: 000180050300011en_US
dc.descriptionPubMed: 12507060en_US
dc.description.abstractObjective: The aim of this study is to investigate the prognostic value of serum acetylcholinesterase levels and their relationship with neurological syndromes (Type I syndrome, intermediate syndrome, and delayed polyneuropathy) in acute organophosphate poisoning. Materials and methods: Thirty-two consecutive patients with acute organophosphate poisoning admitted to the Ondokuz Mayis University Emergency Department from June 1999 to January 2001 were evaluated. Patients were assessed according to admission time, symptoms, and results of clinical exams and their serum acetylcholinesterase levels were determined on days 1, 2, 3, 7, and the last day. Results: There was no significant difference between the first-day serum acetylcholinesterase of the patients with severe poisoning (n = 22, 68.75%) and of the patients with mild poisoning (n = 10, 31.25%; NS). There was no discernible difference between the serum acetylcholinesterase obtained on days I and 3 after poisoning from the patients with intermediate syndrome (n = 5, 15.6%; means: 0.90 +/- 0.65 vs. 0.88 +/- 0.53, 19.35 vs. 18.92%; NS, sensitivity = 80%; specificity = 87.5%). There was a significant difference between the serum acetylcholinesterase obtained on days I and 3 from the patients with nonintermediate syndrome (n = 24, 75%; means: 1.05 +/- 0.24 vs. 1.68 +/- 0.29, 22.58 vs. 36.12%; p < 0.001). There was no discernible significant difference in serum acetylcholinesterase between the patients with organophosphorus-induced delayed polyneuropathy (n = 7, 21.8%) and nonorganophosphorus-induced delayed polyneuropathy. In the patients who died (n = 5, 15.6%), serum acetylcholinesterase showed no discernible increase day 1-the last day (means: 0.50 +/- 0.25 vs. 0.46 +/- 0.26, 10.75 vs. 9.89%; NS). There was a significant difference between the serum acetylcholinesterase levels obtained on days I and the last day from the patients who survived (n = 27, 84.3%; means: 1.14 +/- 0.25 vs. 2.32 +/- 0.26, 24.51 vs. 49.89%; p < 0.001). Conclusion: In the acute phase of organophosphate poisoning, low serum acetylcholinesterase (> 50% of minimum normal value) supports the diagnosis of organophosphate poisoning but it does not show a significant relationship to the severity of poisoning (NS). The serum acetylcholinesterase activity may be a useful parameter in following the acute prognosis of organophosphate poisoning.en_US
dc.language.isoengen_US
dc.publisherMarcel Dekker Incen_US
dc.relation.isversionof10.1081/CLT-120016962en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSerum acetylcholinesterase and prognosis of acute organophosphate poisoningen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume40en_US
dc.identifier.issue7en_US
dc.identifier.startpage903en_US
dc.identifier.endpage910en_US
dc.relation.journalJournal of Toxicology-Clinical Toxicologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster